🔗 Visit the ClinicalTrials.gov page for NCT00046228
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Facilitated PCI in patients with ST-elevation myocardial infarction. | N Engl J Med | 2008 | 2.61 |
| 2 | Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events). | JACC Cardiovasc Interv | 2010 | 1.45 |
| 3 | Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals. | JACC Cardiovasc Interv | 2009 | 1.35 |
| 4 | 1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial. | JACC Cardiovasc Interv | 2009 | 0.86 |